Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (IDA & IBRD countries)
Europe & Central Asia (IDA & IBRD countries): Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 20.8% in 2021. ▼ Falling
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (IDA & IBRD countries), 2000–2021
Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.
Analysis
Europe & Central Asia (IDA & IBRD countries) recorded 20.8% for mortality from cvd, cancer, diabetes or crd between exact ages 30 and in 2021. That is the lowest value across all 22 years on record.
That represents a change of down 1.6% on the previous year and down 19.8% over ten years.
Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (IDA & IBRD countries) peaked at 32.3% in 2000 and was at its lowest, 20.8%, in 2021.
That places Europe & Central Asia (IDA & IBRD countries) 19th out of 47 groups with data for 2021, putting it in the middle of the range.
The long-run direction has been consistently falling across the 22 years of available data.
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia (IDA & IBRD countries), year by year
| Year | % | Change |
|---|---|---|
| 2000 | 32.3% | — |
| 2001 | 31.9% | -1.0% |
| 2002 | 32.1% | +0.7% |
| 2003 | 32.0% | -0.6% |
| 2004 | 31.3% | -2.0% |
| 2005 | 31.4% | +0.4% |
| 2006 | 30.0% | -4.6% |
| 2007 | 29.0% | -3.2% |
| 2008 | 28.6% | -1.5% |
| 2009 | 27.7% | -3.3% |
| 2010 | 27.1% | -2.3% |
| 2011 | 25.9% | -4.3% |
| 2012 | 25.1% | -3.1% |
| 2013 | 24.3% | -3.2% |
| 2014 | 24.7% | +1.7% |
| 2015 | 23.6% | -4.2% |
| 2016 | 23.4% | -1.0% |
| 2017 | 22.7% | -3.1% |
| 2018 | 22.6% | -0.3% |
| 2019 | 22.0% | -2.9% |
| 2020 | 21.1% | -4.0% |
| 2021 | 20.8% | -1.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 30.6% | 27.7% | 32.3% | 10 |
| 2010s | 24.1% | 22.0% | 27.1% | 10 |
| 2020s | 20.9% | 20.8% | 21.1% | 2 |
Countries ranked near Europe & Central Asia (IDA & IBRD countries)
More health data for Europe & Central Asia (IDA & IBRD countries)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.34 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0402 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -0.0639 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0397 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -0.1882 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.035 units per person (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (IDA & IBRD countries)?
- Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia (IDA & IBRD countries) was 20.8% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
- What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia (IDA & IBRD countries)?
- The highest recorded value was 32.3% in 2000.
- What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia (IDA & IBRD countries)?
- The lowest recorded value was 20.8% in 2021.
- How does Europe & Central Asia (IDA & IBRD countries) rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Europe & Central Asia (IDA & IBRD countries) ranks 19th out of 47 groups with data for 2021.
- Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Europe & Central Asia (IDA & IBRD countries)?
- Over the last ten years it is down 19.8%. The long-run trend across the full record is falling.
- Where does this Europe & Central Asia (IDA & IBRD countries) data come from?
- The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).